天山生物(300313.SZ)澄清:上海智本正業從事配資業務等信息為不實傳聞
格隆匯9月11日丨天山生物(300313.SZ)公告稱,近日,公司關注到有媒體報道稱“令人頗感意外的是,層層控股天山生物的上海智本正業,其實是一家股票配資公司,據其官網介紹,上海智本正業投資管理有限公司是經中國證監會核准的股票配資證券投資諮詢機構,主要從事證券軟件研發、金融信息服務等業務。公司提供股票配資服務,槓桿在2-12倍之間,VIP會員配資槓桿11-12倍,最高可配2000萬元。”
公司第一時間關注到上述報道並立即展開了認真核實,為了避免對投資者造成誤導,現予以澄清説明。
(一)傳聞中關於上海智本正業從事配資業務等信息為不實傳聞
上海智本正業系公司控股股東天山農牧業發展有限公司的控股股東,一直從事農業投資管理,從未從事過股票配資業務。上述傳聞均為不實傳聞,鑑於不實傳聞可能誤導投資者,影響正常市場秩序,公司對不實傳聞的發佈者予以強烈譴責,並保留追究法律責任的權利。
(二)關於傳聞相關情況的説明
經上海智本正業核實確認,其網站域名已於2020年3月21日到期,到期後已無官網。根據域名信息查詢結果,該域名已被註冊人dropcatch.com重新註冊,並沿用原ICP備案信息,假冒上海智本正業名義,盜用並篡改上海智本正業營業執照,利用並篡改其它公司網站展示的資質、許可證等照片,P圖修改為“智本正業”,進行非法活動,其行為已嚴重侵害上海智本正業的合法權益,損害上海智本正業的名譽,上海智本正業將採取一切合法措施追究侵權者責任。上海智本正業已將該事項向上海浦東新區網安中心舉報,並向上海市通信管理局發出ICP備案註銷申請。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.